ArticleScience translational medicine2021

Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern.

Hyeseon Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.